Skip to main content

Table 4 Loss of heterozygosity in breast tumors from carriers of putative breast cancer-associated ATM variants

From: Rare variants in the ATMgene and risk of breast cancer

Nucleotide change

Effect

Site

Identifier

LOH

c.170G > A

Protein truncating

Ontario

43115

No LOH

c.442_446 delGACAT

Protein truncating

kConFab

62558

LOH of variant

c.1924G > T

Protein truncating

Ontario

91015

No LOH

c.3802delG

Protein truncating

kConFab

81253

LOH of variant

c.3802delG

Protein truncating

Ontario

43147

No LOH

c.5623C > T

Protein truncating

kConFab

31015

LOH of variant

c.7271T > G

Align GVGD C65

kConFab

40012

No LOH

c.7271T > G

Align GVGD C65

kConFab

40032

LOH of wild type

c.7271T > G

Align GVGD C65

kConFab

40034

No LOH

c.7271T > G

Align GVGD C65

kConFab

70246

No LOH

c.7271T > G

Align GVGD C65

kConFab

60567

No LOH

c.7271T > G

Align GVGD C65

kConFab

20723

No LOH

c.7271T > G

Align GVGD C65

kConFab

51297

50% LOH of variant

c.7271T > G

Align GVGD C65

kConFab

00574

No LOH

c.7638_7646del9

Align GVGD C65

Ontario

91494

No LOH

c.7886_7890delTATTA

Protein truncating

kConFab

31277

LOH of variant

c.8734A > G

Align GVGD C65

Ontario

62131

LOH of variant

  1. ATM, ataxia telangiectasia mutated; kConFab, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer; LOH, loss of heterozygosity.